These compounds have been shown to modulate various signaling pathways, including NF-κB, JAK-STAT, and AP-1, thereby reducing cancer-associated inflammation (White et al., 2016; Taniguchi and Karin, 2018). This evidence concerns the gene NFKB1 and cancer.